1. Home
  2. |Professionals
  3. |Matthew Moisan

Matthew Moisan

Partner | He/Him/His
Partner | He/Him/His
bW1vaXNhbkBjcm93ZWxsLmNvbQ==
VCardLinkedIn
VCardLinkedIn

Areas of Focus

Overview

Matthew Moisan is a co-lead of the Emerging Companies and Venture Capital practice and a resident in the firm's New York City office. He represents ECVC clients in structuring, formation, growth, and exits while providing practical, effective, business-minded counsel based on a keen awareness of the entrepreneurial lifecycle. Matthew has a unique way of deciphering his clients’ goals and an ability to turn complex legal issues into actionable business items. While his representation often begins when a company is merely an idea on the back of a napkin, he is also frequently engaged when the stakes are the highest: negotiating the sale of the business.

Additionally, Matthew has significant experience representing venture capital, hedge funds, and private equity funds in private company investments. His representation of parties on both sides of these transactions enables him to anticipate the opposition’s concerns, resulting in a more efficient and favorable outcome for his clients.

He currently serves on the New York City Bar Emerging Companies and Venture Capital Committee. Matthew was previously the chair of the Emerging Companies and Venture Practice Group of an Am Law 200 firm, an adjunct professor at Parsons School of Design where he taught Business Regulations and Practices, and chairman of the New York State Bar Association’s Business Organizations Committee.

Career & Education

|

    • Boston University, B.A., 2005
    • Touro College Jacob D. Fuchsberg Law Center, J.D., 2008
    • Boston University, B.A., 2005
    • Touro College Jacob D. Fuchsberg Law Center, J.D., 2008

    • New York
    • New York

Matthew's Insights

Event | 10.18.24

Health Tech Investor Event: Bridging European Innovation and U.S. Markets

Join us for an exclusive event in New York City, where European startups meet investors eager to bring groundbreaking healthtech solutions to the American market.

View All Insights

Insights

Event | 10.18.24

Health Tech Investor Event: Bridging European Innovation and U.S. Markets

Speaking Engagement | 10.18.24

Health Tech Investor Event: Bridging European Innovation and U.S. Markets

Firm News | 1 min read | 07.16.24

Crowell & Moring Advises itselectric in $6.5 Million Seed Funding Round

Event | 06.06.24

New York Smart Business Dealmakers Conference
|

View All Insights